Authors: Hehrlein, C DeVries, JJ Wood, TA Haller, SD Arab, A Kloostra, AC Lauer, MA Fischell, TA

Citation: C. Hehrlein et al., Overestimation of stent delivery balloon diameters by manufacturers' compliance tables: A quantitative coronary analysis of duet and NIR stent implantation, CATHET C IN, 53(4), 2001, pp. 474-478

Authors: Mawhorter, SD Lauer, MA

Citation: Sd. Mawhorter et Ma. Lauer, Is atherosclerosis an infectious disease?, CLEV CLIN J, 68(5), 2001, pp. 449-458

Authors: Lauer, MA Houghtaling, PL Peterson, JG Granger, CB Bhatt, DL Sapp, SK Simoons, ML Harrington, RA Topol, EJ Lincoff, AM

Citation: Ma. Lauer et al., Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acutecoronary syndromes - Observations from the platelet IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial, CIRCULATION, 104(23), 2001, pp. 2772-2777

Authors: Lauer, MA

Citation: Ma. Lauer, Inflammation and infection in coronary artery disease, CONTEMP CAR, 2001, pp. 47-64

Authors: Ziskind, AA Lauer, MA Bishop, G Vogel, RA

Citation: Aa. Ziskind et al., Assessing the appropriateness of coronary revascularization: The University of Maryland Revascularization Appropriateness Score (RAS) and its comparison to RAND Expert Panel Ratings and American College of Cardiology American Heart Association guidelines with regard to assigned appropriateness rating and ability to predict outcome, CLIN CARD, 22(2), 1999, pp. 67-76

Authors: Lauer, MA Lincoff, AM

Citation: Ma. Lauer et Am. Lincoff, Parenteral direct antithrombins, HANDB EXP P, 132, 1999, pp. 331-352